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Summary 
The worldwide increase in disability and death rates due to non-communicable and 
infectious diseases may partly be attributed to the expense, inaccessibility and 
severe side effects of current treatment strategies. Medicinal plants provide an 
avenue to discover and develop cheap, safe yet potent alternative therapies that 
are easily accessible and culturally acceptable. This study evaluated the bioactivity 
of extracts from Gnidia polycephala and Senecio serratuloides in order to assess 
their potential for drug development. 
The acetone, methanol and aqueous plant extracts were tested for anticancer 
activity as well as for cytotoxicity in vitro using the Sulforhodamine B assay. The α-
amylase and α-glucosidase inhibition assays were used to evaluate their potential 
as hypoglycemic agents. The antimicrobial efficacy of the plant extracts against 
specific bacteria was determined by means of the broth microdilution method. The 
phytochemical constituents of the plant extracts were detected using standard 
qualitative phytochemical screening techniques as well as Gas chromatography. 
The extracts from Gnidia polycephala and Senecio serratuloides had weak (IC50) 
or no anticancer activity against renal, melanoma and breast cancer cell lines. The 
extracts were also classified as low or weak hazard against the normal human fetal 
lung fibroblast cell line and were selective for the cancer cells and could therefore 
be safe to use. The acetone extract from G. polycephala showed good α-amylase 
inhibition at 66.34 ± 0.84%; while G. polycephala acetone (81.75 ± 0.86%), 
aqueous (54.84 ± 0.65%) and methanol (45.43 ± 0.56%) extracts and S. 
serratuloides acetone (78.86 ± 1.10%) extract showed good anti-α-glucosidase 
activity. Only S. aureus was susceptible to G. polycephala acetone and methanol 
extracts at 10 mg/ml and susceptible to S. serratuloides acetone and methanol 
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extracts at 5 mg/ml. Hydrolysable tannins were detected in extracts from both 
plants, while flavonoids were detected in S. serratuloides extracts. Few medically 
important compounds such as 4-((1E)-3-Hydroxy-1-propenyl)-2-methoxyphenol 
and 2-Methoxy-4-vinylphenol were identified using Gas chromatography/mass 
spectrometry (GCMS). The G. polycephala extracts showed higher α-amylase and 
α-glucosidase enzymes inhibitory activities than the extracts from S. serratuloides 
and further fractionation of these extracts to determine which compounds are 
responsible for the α-amylase and α-glucosidase inhibition as well as to determine 
if the inhibition is as a result of the compounds acting synergistically or individually 
is recommended. 
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CHAPTER 1 
INTRODUCTION 
Health-care systems across many disease endemic countries are noticeably weak 
(World Health Organization (WHO), 2012) and continue to be pressurized by the 
ever increasing morbidity and mortality rates associated with non-communicable 
(Saeed et al., 2015) and infectious diseases (Mothana et al., 2011). The current 
treatment strategies (chemotherapy, hypoglycemic agents and antibiotics) face a 
serious challenge of drug resistance (Saeed et al., 2015) and severe side effects 
(Manosroi et al., 2015). These strategies are also not readily available to all citizens 
of developing countries (Sakarkar and Deshmukh, 2011) and patients cannot 
afford the prescribed treatment drugs (WHO, 2012). This imposes the need to 
discover and develop cost effective, safe and potent alternative therapies 
(Sakarkar and Deshmukh, 2011). Medicinal plants have gained interest from 
researchers across the world as alternative sources of new drug leads (Manosroi 
et al., 2015). 
 
1.1 Non-communicable diseases 
Over the past decade, there has been growing concern over the rapid increase in 
the occurrence and prevalence of non-communicable diseases (NCDs) (Reubi et 
al., 2016) and consequently, the health and economic burdens they place on 
healthcare systems worldwide (Katende and Becker, 2016). NCDs are 
accountable for about 38 million annual deaths worldwide where cardiovascular 
diseases, cancers, chronic respiratory disease and diabetes cause an 
overwhelming 82% of the 38 million annual deaths (WHO, 2014). The current 
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annual death rate associated with non-communicable disease is expected to 
increase worldwide, and the biggest increase is predicted to occur in the low-and-
middle income countries (Samoisy and Mahomoodally, 2015). 
The prevalence of NCDs has been escalated to outrank infectious diseases as the 
world’s leading cause of death (de Wet et al., 2016); resulting in more annual 
deaths than those caused by all other diseases combined (Chintamunnee and 
Mahomoodally, 2012). This is a result of the globalization of unhealthy lifestyles 
such as the excessive indulgence in alcohol, unhealthy diets, physical inactivity, 
excessive body weight as well as changes due to urbanization which might cause 
persistent stress (Shinkafi et al., 2015). 
Remarkable advances in the development of medicines and prevention strategies 
made available in the fight against NCDs have been observed. However, the 
management and control of NCDs has remained largely insufficient and NCDs 
continue to cause deaths worldwide (Samoisy and Mahomoodally, 2015). For 
instance, in Sub-Saharan Africa, the focus of prevention and treatment is mainly 
directed towards communicable diseases such as Human immunodeficiency virus 
(HIV), Tuberculosis (TB) and malaria, whereas the remaining non-communicable 
diseases are ignored. This has led to overwhelming mortality and morbidity rates 
(Katende and Becker, 2016). 
 
1.1.1. Cancer 
Across the world, cancer is a leading cause of death and disability and impacts 
more than 14 million people yearly (WHO, 2015a). It is responsible for about 8.2 
million deaths reported each year (which is 13% of all mortality cases). A 70 % 
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increase in new cancer cases is expected over the next twenty years (WHO, 2016). 
Although the current global cancer rates may remain the same, the projected 
incidence of 8.7 million new cancer cases reported in 2008; will eventually reach 
12.6 million by 2030 (WHO,2014). Further projections predict that 27 million new 
cancer cases and 17.5 million cancer deaths will be reported worldwide by 2050 
(Senthilkumar et al., 2014). 
More than two thirds of all cancer deaths occur in low- and middle-income 
countries. Lung, breast, colorectal, stomach and liver cancers together are 
responsible for more than half of all cancer related deaths in these countries. In 
high-income countries, lung cancer is the leading cause of cancer deaths among 
both males and females, and is followed by breast cancer amongst females and 
colorectal cancers amongst males. The cancer levels in low-and middle-income 
countries vary as compared to those in high-income countries according to the 
prevailing underlying risks. In low-and middle-income countries; cervical cancer, 
liver cancer and stomach cancer all cause a larger proportion of cancer deaths as 
compared to high-income countries. For instance; in sub-Saharan Africa, cervical 
cancer remains the leading cause of death among females (WHO, 2014). 
The main methods of treatment for human cancers may involve surgery, radiation 
therapy and chemotherapeutic drugs, and at times a combination of all three or 
two of these methods are employed (Houghton et al., 2007). These interventions 
can temporarily relieve symptoms, prolong life, and occasionally cure the disease 
(Sakarkar and Deshmukh, 2011). 
However, cancer patients have often suffered unpleasant and severe side effects 
associated with chemotherapy treatment (Manosroi et al., 2015). This is because 
most of the anticancer agents influence the process of cell proliferation; and not 
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only for the cancer cells, but for the normal cells as well. These include cells in the 
bone marrow, oral mucosal cells and hair follicles. The most common side effects 
include nausea and vomiting as a result of the damage in the epithelium covering 
the gastrointestinal tract caused by these anticancer agents. Some other common 
side effects include diarrhea, dyspepsia, and constipation, all because of the 
damage incurred by the intestinal epithelium. Moreover, chemotherapy is often 
associated with hair loss, fatigue, sexual dysfunction, anxiety, and oral ulcers 
which, in turn cause taste and smell dysfunctions (Krukiewicz and Zak 2016; Li et 
al., 2016). Furthermore, there is a limited survival outcome as shown by metastatic 
pancreatic cancer patients in the United States who were treated with the first-line 
chemotherapeutic drug; Gemcitabine (Sherine et al., 2010). Additionally, synthetic 
anticancer drug treatments are not easily accessible to the residents of the rural 
areas. Therefore, there is an urgent need for alternative treatment and 
management strategies of cancer (Sakarkar and Deshmukh, 2011). 
 
1.1.2. Diabetes 
About 285 million people between 20 and 79 years of age were diagnosed with 
diabetes in 2010 (Trinh et al., 2016). Furthermore, about 415 million people 
worldwide were diagnosed with this disease in 2015. It is predicted that diabetes 
will affect 552 million people by 2030. A further 642 million adults are predicted to 
be diagnosed with diabetes by 2040, which is one in every ten adults. In addition, 
66.7% of diabetics do not know their hyperglycaemic status. About 14.2 million of 
the diagnoses made in 2015 were made in Africa alone; and estimates predict that 
in 2040; 34.2 million diagnoses would be made in Africa alone. Consequently, the 
management and treatment of diabetes amounts to 12% of the total global health 
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expenditure (International Diabetes Federation (IDF), 2015; Wannes and Marzouk, 
2016). 
Diabetes can be treated using the different types of synthetic oral hypoglycaemic 
agents and insulin. However, these synthetic agents may produce severe side 
effects and toxicity, and insulin cannot be administered orally (Xu et al., 2015). The 
side effects of synthetic hypoglycaemic drugs include severe hypoglycaemia, lactic 
acidosis, peripheral oedema and abdominal discomfort (Wannes and Marzouk, 
2016). Furthermore, the use of thiazolidinediones which are widely used in the 
treatment of type II diabetes is associated with weight gain; which is a risk factor 
for many other NCDs. Again, Liraglutide, a GLP (Glucagon-like peptide) -1 analog, 
which is used to improve glycaemic control in type II diabetic adults, was found to 
cause thyroid C-cell tumours in rodents. It is still to be established whether 
liraglutide causes thyroid C-cell tumours in humans or not (Aguilar, 2011). As a 
result, there is an urgent need for the development of cheaper, safer and effective 
anti-diabetic agents from natural materials (Xu et al., 2015). 
 
1.2. Infectious diseases 
Throughout history, mankind has always been tormented by infectious diseases 
which have always remained a major cause of mortality and disability; making them 
the second leading cause of death worldwide (EL-Zawahry et al., 2013). Infectious 
diseases were responsible for the deaths of more than 8.7 million people worldwide 
in 2008 and have continued to kill almost 9 million people every year and have also 
caused enormous burdens through life-long disability. A large number of these 
deaths were poor residents living in low and middle-income countries, with the 
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majority of the deaths occurring in children under the age of five. This is commonly 
due to the misdiagnosis and under-detection of these diseases in healthcare 
systems of impoverished areas. Ultimately, infectious diseases continue to place 
significant health and economic burdens on poor populations across the world 
(WHO, 2012). 
Bacterial existence in the environment and their interactions with humans is a 
major cause of most infections and diseases (Upadhyay et al., 2014). Diseases 
related to bacterial infections are orchestrated by a series of virulent factors which 
facilitate several aspects of their pathophysiology critical for disease in the host. 
These include amongst others, adhesins and membrane proteins that mediate 
bacterial attachment, colonization, and invasion of host cells. Additionally, 
microbial toxins result in host tissue damage, and bacterial cell wall components 
like capsular polysaccharides confer resistance against the host’s immune system 
(Kao et al., 2016). Further virulent factors such as biofilm formation and spore 
forming capacity assist in the existence and persistence of pathogens in harsh 
environmental conditions (Upadhyay et al., 2014). Some common 
enteropathogenic microbes and the associated diseases are listed in Table 1.1. 
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The development of antimicrobial resistance is a natural phenomenon. In this 
instance, microorganisms replicate themselves erroneously or exchange resistant 
traits with other microorganisms (WHO, 2015b). The inappropriate use of 
antimicrobial drugs further accelerates the emergence and spread of drug-
resistant strains (Ahmed et al., 2014; Wikaningtyas and Sukandar, 2016). This 
greatly threatens the human ability to treat common infectious diseases. Infections 
resulting from resistant microorganisms often cannot be treated with the standard 
treatment drugs, causing extended periods of illness, high health care expenses, 
and a greater risk of loss of life and disability (EL-Zawahry et al., 2013). The death 
toll in patients with serious infections associated with common bacteria treated in 
hospitals is almost twice that seen in patients with infections caused by the same 
non-resistant bacteria. For instance, patients with methicillin-resistant 
Staphylococcus aureus, (MRSA) are estimated to be 64% more likely to die than 
patients with a non-resistant form of the infection (Wikaningtyas and Sukandar, 
2016; Aumeeruddy-Elalfi et al., 2015). 
1.3. The link between cancer, diabetes and infectious diseases 
Epidemiological research and meta-analysis centred on both comparative and 
cohort studies have shown an association between diabetes and the incidence and 
mortality as a result of cancer. Increased cancer risk in type II diabetes refers to 
liver, pancreatic, colorectal, kidney, endometrial and breast cancer (Tokajuk et al., 
2015). Patients with diabetes have a higher risk of developing a number of severe 
health problems as compared with patients without diabetes. This is because 
consistently high blood glucose levels can ultimately lead to problems in the 
functioning of the heart and blood vessels, eyes, and the kidneys (IDF, 2015, Trinh 
et al., 2016). Additionally, people with diabetes also have a higher risk of 
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developing infections. Even though the risk factors for type I diabetes are still being 
researched, exposure to some viral infections has been directly linked to the risk 
of developing type I diabetes (IDF, 2015). 
According to the World Health Organization (2012), infectious diseases frequently 
contribute to the chronic NCD burden. For instance; 28% of bladder cancer cases 
in Bulawayo, Zimbabwe were accounted for by urinary schistosomiasis (caused by 
trematodes of the genus Schistosoma). Similarly, there was a case reported in the 
east and south-eastern Asia where the outbreak of Fish-borne liver fluke infections 
(that trigger liver and bile duct cancers) was seen. During this period, the highest 
incidence of liver and bile duct cancer in the world was reported in this region. 
Emerging reports highlighted a link between the infections and cancers amongst 
Thai males (WHO, 2012). Chronic inflammation as a result of infectious disease is 
perceived to be responsible for above 15% of currently known cancers (Sideras 
and Kwekkeboom, 2013). 
Evidence also suggests the direct association of the Helicobacter pylori infection 
with metabolic diseases including type II diabetes mellitus. H. pylori infection alters 
the secretion of metabolic hormones which aggravates insulin resistance (He et 
al., 2016). Furthermore, H. pylori infection is also reported as the most common 
risk factor of gastric cancer, responsible for above 70% of all gastric cancer cases 
(Yang et al., 2016). 
Ultimately, NCDs add to the burden of disease for individuals, communities and 
countries that are already struggling to cope with the infectious disease (WHO, 
2012). 
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1.4. The use of medicinal plants as alternative medicines 
The oldest and most diverse of all known medicinal systems currently in use; is the 
African traditional medicine (Shinkafi et al., 2015). From antiquity, humans have 
used plants or their parts to treat most of their ailments, and this knowledge has 
been passed from generation to generation. Fossils provide evidence that since 
approximately 60 000 years ago, humans have used plants as medicine (Elgorashi 
et al., 2003). 
Most residents of developing countries continue to rely on the use of traditional 
medicinal plants as a primary health care resource, mainly because traditional 
medicinal plants are widely available and affordable. Furthermore, the use of 
traditional medicinal plants is also generally found to be culturally and spiritually 
acceptable (Verschaeve et al., 2004). 
To date, about 80% of the population in the developing world depend on and utilize 
plants and/or their derivatives for primary health-care (Sakarkar and Deshmukh, 
2011; Sher et al., 2016). In South Africa, approximately 60% of the total population 
consults one of about 200 000 traditional healers, who mainly prescribe the use of 
certain plant derivatives (Fuku et al., 2013). 
There is an estimation of about 350 000-420 000 plant species that exist on earth 
but, documented knowledge about their medicinal use is very limited (Pan et al., 
2013; Sher et al., 2016). South Africa, in its entirety, is home to a unique and 
diverse botanical heritage having above 30 000 plant species (Fouche et al., 2008; 
van Vuuren, 2008) of which only about 10% are used as medicine (van Vuuren, 
2008). This is a clear indication that most of the medicinal plants in South Africa 
are currently not sufficiently documented possibly because this knowledge is only 
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transmitted by oral instruction from generation to generation without the assistance 
of a formal writing system because most traditional healers do not keep written 
records (Mahwasane et al., 2013). 
The therapeutic properties of plants are attributed to the presence of secondary 
metabolites (Fuku et al., 2013), which have been significantly applied in modern 
therapy (Aziz et al., 2016; Sher et al., 2016). For instance, 61% of 877 molecules 
used in drug development between 1981 and 2002 were naturally derived or 
inspired. Only the remaining 39% was truly synthetic in origin (Fuku et al., 2013). 
As a result, naturally derived plant products are the best sources for novel drug 
targets. Some of the modern drugs that have been developed from plants include 
amongst others, aspirin, metformin, morphine and quinine (Chintamunnee and 
Mahomoodally, 2012). Benzoin and emetine; were also isolated from plants and 
are known to inhibit microorganisms (Barbour et al., 2004). Despite this, scientific 
knowledge of the therapeutic potential of most plants is very limited (Pan et al., 
2013). 
 
1.5. The use of medicinal plants in the treatment of cancer, diabetes and 
infectious disease 
Some of the medicinal plants involved in the treatment and management of cancer; 
protect the human body from cancer by enhancing the body’s detoxification 
functions, while some are known to hinder the proliferation of cancer cells by 
modulating the activity of certain hormones and enzymes. For instance, 
phytochemicals extracted from Aloe vera and Morinda citrifolia have previously 
been utilized extensively in various formulations that assist the human body to 
more effectively fight cancer and reduce the toxic side effects associated with both 
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radiotherapy and chemotherapy treatments (Sakarkar and Deshmukh, 2011). 
Further examples of plant derived anticancer compounds currently used in patient 
treatment include the therapeutic vinca alkaloids (vinblastine and vincristine), 
camphotecins, taxanes and epipodophyllotoxins (Fuku et al., 2013; Solowey et al., 
2014). 
To date, more than 1200 plant species have been reported across the world as 
anti-diabetic. Recently, the most commonly used anti-diabetic drug which is known 
as Metformin; was developed based on a biguanide compound isolated from the 
plant Syringa vulgaris (French lilac). Similar bioactive compounds isolated from 
other medicinal plants can display multiple actions on insulin production and 
distinct insulin action mechanisms such as insulin sensitizing, insulin mimicking, 
inhibition of intestinal carbohydrate digestion and absorption. Ultimately; these 
actions increase glucose disposal and uptake by muscle and hepatic cells (Kadan 
et al., 2016; Wannes and Marzouk, 2016). 
The combination of plant extracts and existing antibiotics aids to minimize the 
minimum inhibitory concentrations (MIC), enhance synergistic activity and this 
minimizes the multiple side effects of combining synthetic drugs. Furthermore, 
such combinations can be effective in the control of some bacteria that are known 
to exhibit consistently high resistance to antimicrobials by improving the efficacy of 
antibiotics against resistant bacterial pathogens (Abioye et al., 2017). 
Medicinal plants and their natural components have different mechanisms of action 
to that of the conventional drugs when used to treat infections, which are related 
to: 
• the degradation of the cell wall, 
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• damage to the cytoplasmic membrane and membrane proteins, 
• leakage of intracellular contents, 
• coagulation of cytoplasm, 
• interference with active transport or metabolic enzymes, 
• dissipate cellular energy in ATP form, 
• depletion of proton motif force (PMF), and electron flow which can cause 
cell death (EL-Zawahry et al., 2013). 
 
1.6. Gnidia polycephala 
Gnidia polycephala, Gilg. (Fig 1.1) of the family Thymeleaeceae; is one of the 
traditional medicinal plants commonly used in the treatment and prevention of 
human illness in the dry regions of the Southern African countries such as 
Botswana, Zimbabwe and South Africa (Munkombwe et al., 2003). It is a small 
plant with numerous, erect leafless branches, which have a few flowered hairy 
heads, each with a few large, papery bracts below the flowers (Mothogoane, 2013). 
G. polycephala is commonly known as “makgonasotlhe” (which is Setswana for 
‘having the ability to do everything’, referring to the ability of the plant to heal every 
human ailment), and can grow well in areas where other plants are difficult to grow 
and spread (Munkombwe et al., 2003). 
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Fig 1.1: Gnidia polycephala (Source: www.plantsystematics.org) 
Preparations of G. polycephala are commonly taken orally to stabilize heart 
conditions, treat tuberculosis and tonsillitis, and its ashes are applied onto wounds 
(Munkombwe et al., 2003). However, depending on locality and season, this plant 
can be toxic when consumed by livestock (Munkombwe et al., 2003; Bhandurge et 
al., 2013). In traditional medicine, the roots of the species within the genus are 
used for several kinds of ailments, including constipation, boils, burns, snakebites, 
coughs, insanity and poor appetite, following adherence to the correct and strict 
procedures of preparation (Mothogoane, 2013). 
 
1.7. Senecio serratuloides 
Senecio serratuloides, DC. (Asteraceae) is another of the commonly used 
traditional medicinal plants in the treatment of human ailments. S. serratuloides is 
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a herbaceous perennial plant with an erect stem of up to a meter high, which 
sprouts from a woody rootstock. The leaves are about 60 mm long typically with 
serrated margins and bears small yellow flowers in sparse clusters towards the 
ends of the branches (Fig 1.2). In South Africa, it is found in KwaZulu Natal, 
Limpopo, and Mpumalanga Provinces, where it is commonly known as 
“Insukumbili” (which is isiZulu for ‘two-days’, referring to the healing effect of the 
plant in two days) (van Wyk et al., 2009). 
 
Fig 1.2: Senecio serratuloides (Source: www.ispotnature.org) 
The leaves and the stem of the plant are commonly used for medicinal purposes. 
The leaves of S. serratuloides are applied over cuts, swellings, burns and sores to 
encourage healing which occurs in about two days (van Wyk et al., 2009; Fawole 
et al., 2010). The charred leaf extracts of S. serratuloides reportedly healed deep 
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partial thickness skin wounds in a pig model two days earlier than as was observed 
in the wounds treated with either activated carbon or dressing alone (Gould et al., 
2015). The dried and powdered leaves are also snuffed to treat headaches. To 
purify blood for skin eruptions or swollen gums and chest pains, plant teas are 
taken in small doses (van Wyk et al., 2009; Fawole et al., 2010). Recently, 
anecdotal reports from the traditional healing community claim to use S. 
serratuloides in the treatment of gastric ulcers (Gould et al., 2015). 
The hepatic, renal and pulmonary disorders related to the ingestion of S. 
serratuloides have been attributed to the presence of some of the Pyrrolizidine 
alkaloids (PAs) that are generally found in the species of the genus Senecio (van 
Wyk et al., 2009; Gould et al., 2015). However, there has been no study that has 
to date reported specifically on the presence of these PAs in S. serratuloides. 
Following the hepatotoxicity that has been noted subsequent to accidental 
ingestion, S. serratuloides has been classified as a poisonous plant by the South 
African National Biodiversity Institute (SANBI, 2010) (Gould et al., 2015). 
According to Hol and Van Veen (2002), PAs cause severe liver damage in many 
mammalian species sometimes resulting in death. This demands thorough 
cytotoxicity testing of the Senecio species. 
 
1.8. Aim of the study 
The current study was conducted with the aim to evaluate the bioactivity of the 
acetone, methanol and aqueous extracts from Gnidia polycephala and Senecio 
serratuloides. 
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1.9. Objectives of the study 
1. To determine the anticancer activity of the acetone, methanol and aqueous 
extracts form Gnidia polycephala and Senecio serratuloides. 
2. To evaluate the antidiabetic activity of the plant extracts. 
3. To assess the antimicrobial activity of the plant extracts against common 
pathogens. 
4. To characterize the phytochemical composition of the plant extracts. 
5. To establish the safety of the extracts from the plants in question through 
cytotoxicity assays. 
 
1.10. Chapter outline 
This study is presented in six chapters. Chapter two presents the anticancer 
activities and cytotoxic effects of the acetone, methanol and aqueous extracts from 
Gnidia polycephala and Senecio serratuloides using the Sulforhodamine B (SRB) 
assay. The ability of the plant extracts to inhibit the carbohydrate-hydrolyzing 
enzymes, α-amylase and α-glucosidase (antidiabetic activity) are dealt with in 
chapter three. The fourth chapter is an assessment of the antimicrobial activity of 
the plant extracts against common pathogens while the fifth chapter presents the 
phytochemical composition of the extracts. A general discussion of the results of 
the study and conclusions are presented in the final chapter. 
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CHAPTER 2 
ANTICANCER EFFECTS AND CYTOTOXICITY OF EXTRACTS FROM GNIDIA 
POLYCEPHALA AND SENECIO SERRATULOIDES  
2.1. Introduction 
Cancer can be described as a wide group of different diseases characterized by 
unregulated cell growth (Ochwang’i et al., 2014). Cell division and growth in a 
cancerous state, is uncontrollable and often results in tumors that, if malignant, can 
metastasize and disrupt the surrounding tissues (Tagne et al., 2014). Cancer cells 
continually divide even in conditions where normal cells would normally await a 
special chemical transduction signal. The cancerous cells disregard similar stop 
signals as they are sent out by neighboring tissues. These cancer cells are 
immortal even in in vitro conditions while normal cells cease dividing after 50-70 
generations and normally undergo cell apoptosis; which is their genetically directed 
programmed death (Sakarkar and Deshmukh, 2011). 
The World Health Organization (WHO, 2014) projects increases in the worldwide 
mortality rate due to cancer. Currently, the exact causes in the ever increasing 
cases of cancer are still unknown (Ochwang’i et al., 2014). Nonetheless, scientific 
evidence attributes a large number of cancer cases to the changes in 
deoxyribonucleic acid (DNA) that eradicate or reduce the normal controls over cell 
proliferation, maturation and apoptosis (Sakarkar and Deshmukh, 2011). In many 
cases, free-radical reactions that are generally important in numerous metabolic 
processes could also be harmful to human health. For instance, free radicals like 
reactive oxygen species (ROS) i.e. hydroxyl radicals, superoxide anions and 
hydrogen peroxide play a vital role during the development of tissue damage in 
humans. Scientific research relates the occurrence of cancer to oxidative damage 
to DNA, proteins and lipids; as caused by radicals and other carcinogens (Ahmadi 
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et al., 2010; Mothana et al., 2011; Mhaladi et al., 2013). 
The cause of cancer in patients with certain genetic profiles or in patients infected 
with chronic viruses (viral hepatitis can cause liver cancer, HIV can cause 
lymphoma), is commonly due to exposure to carcinogenic chemicals and/or 
radiation, together with the inability of the immune system to eradicate the cancer 
cells at an early stage during their proliferation (Sakarkar and Deshmukh, 2011). 
Furthermore, risk factors including the use of tobacco, radiation, some infections, 
obesity, poor diet and environmental pollutants, are all also known to be the major 
factors leading to the development of cancer. These risk factors can cause damage 
to the genes directly or act in combination with other existing genetic disorders 
within body cells to cause the disease (Ochwang’i et al., 2014). 
For decades now, chemotherapy has always been an important option and the 
hallmark of cancer therapy. Regardless of the outstanding role chemotherapy has 
played in cancer treatment, the development of drug resistance and severe side 
effects have limited its success in cancer therapy (Saeed et al., 2015). As a result, 
the focus has now shifted towards the discovery and development of new 
alternative treatments and management approaches that target specific molecules 
associated with the development and progression of tumors. Following this new 
approach, several strategies are suggested in the quest for novel antitumor drugs. 
These strategies consider naturally occurring compounds as a source of novel 
cancer therapies (Solowey et al., 2014; Manosroi et al., 2015). Naturally occurring 
compounds isolated from medicinal plants used in the treatment of cancer are 
known to possess multiple targets and therefore are favored over the mono-
targeting drugs (Senthilkumar et al., 2014). 
Over the recent decade; chemoprevention with the use of plant metabolites to 
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subdue, block or reverse the process of carcinogenesis is receiving great attention 
from researchers (Senthilkumar et al., 2014). Global interest for the discovery and 
development of new drugs especially from traditionally used medicinal plants is 
ever growing (Mhaladi et al., 2013). More and more medicinal plants have been 
investigated in the search for alternatives to synthetic agents. Actually, a large 
number of plants have been used in traditional medicines with great potency and 
safety (Manosroi et al., 2015) and such medicinal plants are perceived as a 
valuable source of bioactive compounds useful in the therapies of a majority of 
diseases including cancer; across almost all ethnic groups and for over thousands 
of years (Ochwang’i et al., 2014). Certain groups of phytochemicals found in 
vegetables and fruits, like terpenoids, phenolic acids, tannins, quinones, 
coumarins, flavonoids, carotenoids, and vitamins have been investigated and have 
showed great potential as chemopreventive agents in the treatment of cancer 
(Senthilkumar et al., 2014; Tagne et al., 2014). A few examples of the many 
medicinal plants that are increasingly becoming an integral component of the 
ethnomedical approach in the treatment of cancer include the leaves, fruits of 
Moringa oleifera Lam (Saeed et al., 2015), Catharanthus roseus L., Aloe volkensii 
Engl. (Ochwang’i et al., 2014), Ammania baccifera L. and Polygala chinensis L 
(Houghton et al., 2007). 
When used in chemotherapy, compounds extracted from medicinal plants work 
either by targeting the rapidly dividing cells by impairing mitosis or causing 
apoptosis of the target cells (Ochwang’i et al., 2014). The success of medicinal 
plants as anticancer agents could also be due to their redox properties (Kilani-
Jaziri et al., 2011). Medicinal plants have the ability of scavenging oxygen free 
radicals that are suspected to be involved in the development of many diseases 
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including cancer (Mothana et al., 2011) and the ability to quench singlet and triplet 
oxygens, or decomposing peroxides (Kilani-Jaziri et al., 2011). Thus, a thorough 
understanding of the complex synergistic interaction of various components of 
anticancer compounds extracted from medicinal plants can be useful in the 
formulations designed to attack and destroy cancerous cells without inducing any 
harm on other normal body cells (Sakarkar and Deshmukh, 2011). 
In South Africa, a collaborative research programme between the U.S. National 
Cancer Institute (NCI) and the Council for Scientific and Industrial Research (CSIR) 
of South Africa has contributed immensely to the discovery of new naturally 
occurring anticancer agents (Fouche et al., 2008). However, scientific reports on 
medicinal plants used in the treatment of cancer remain limited in South Africa 
(Steenkamp and Gouws, 2006). 
Across the world, following their continued use for long periods in traditional 
medicine, medicinal plants are assumed and believed to have very high healing 
effects and minor toxic side effects, as compared to synthetic compounds 
(Verschaeve and Van Staden, 2008; Zeng et al., 2013). The justification for the use 
of medicinal plants has largely relied on long-term clinical experience with very 
minimal or no scientific information on their efficacy and safety (Chanda et al., 
2015). 
Numerous studies on medicinal plant pharmacological properties have suggested 
that the use of extracts from medicinal plants can also cause harm or damage to 
the users (Verschaeve and Van Staden, 2008; Ene-Ojo et al., 2013; Mounanga et 
al., 2015). These studies further show that the aqueous extracts are less toxic than 
organic extracts, probably due to the different phytochemical composition of both 
the aqueous and alcoholic (organic) types of extracts. The relatively low toxicity of 
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the aqueous extracts may be associated with the fact that they include the total 
family of medicinal compounds (both known and unknown) as they may be found 
naturally and thus; pose a less risk of associated side effects (Mounanga et al., 
2015). Medicinal plant toxicity may also be attributed to the incorrect preparation 
and dispensation of the plant extracts (Ene-ojo et al., 2013) as well as the 
prolonged use of some of the popular medicinal plants following the lack of 
regulation of the prescription and use of these medicinal plants in South Africa 
(Fennell et al., 2004). 
Furthermore, the dosage prescribed with the use of medicinal plants is as 
important as in the use with all other medicines. In fact, the administered dose is 
actually proportional to the degree of toxicity. Therefore, the higher the prescribed 
dosage; the more the lesions caused become important particularly in cases of 
regular consumption. A dose that could potentially cause damage varies from one 
plant to another because of the differences in both the chemical compounds 
distributed within the plant and the quantities of these chemical compounds 
(Mounanga et al., 2015). 
In the long run, many commonly used medicinal plants cause acute toxic effects 
(Mounanga et al., 2015). These toxic effects may range from diarrhea, 
hypersensitivity reactions, nausea or vomiting, to organ-targeted toxicity; 
immunotoxicity, embryo/fetal and prenatal toxicity, mutagenicity/genotoxicity, 
hepatoxicity, nephrotoxicity, presence of epileptogenic compounds, cardiac toxins, 
gastrointestinal toxins to carcinogenicity. Some of the other adverse effects may 
include cardiovascular, neurological and dermatologic toxic effects. The ultimate 
adverse effect is death (Bisi-Johnson et al., 2011). As a result, all products used in 
therapeutics; including those of natural origin, must all be subjected to efficacy and 
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safety testing by the same methods as used for new synthetic drugs to determine 
the appropriate dose of such a drug (Chanda et al., 2015). 
This study was carried out to investigate the anticancer potential and the cytotoxic 
effects of extracts from Gnidia polycephala and Senecio serratuloides. 
 
2.2. Methods 
2.2.1. Plant collection, preparation and extraction 
Gnidia polycephala and Senecio serratuloides were collected and identified by 
researchers from the National Museum, Bloemfontein. Voucher specimens (Gnidia 
polycephala NGM 001 and Senecio serratuloides NGM 002) were prepared and 
deposited in the herbarium at the National Museum, Bloemfontein, South Africa. 
The plant material was thoroughly washed, air dried at room temperature and 
ground into fine powder. For this study, the aerial parts (stems, leaves and flowers) 
of G. polycephala and the stems of S. serratuloides were used. Plant sample 
portions of 15 g were separately shaken at 165 RPM in 400 mL acetone, 400 mL 
methanol and 400 mL water for 48 hours. Then the extracts were filtered through 
Whatman No. 1 Filter paper and each filtrate was concentrated to dryness using 
the Genevac Rocket evaporation system. 
 
2.2.2. The Sulforhodamine B (SRB) assay 
The Sulforhodamine B (SRB) (Houghton et al., 2007; Manosroi et al., 2015) assay 
was used to measure the growth inhibitory effects of the investigated plant extracts 
using a 3-cell line panel consisting of TK10 (renal), UACC62 (melanoma) and 
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MCF7 (breast) cancer cells. The WI38 (normal human fetal lung fibroblast) cell line 
was used to evaluate the cytotoxicity of the plant extracts. 
The SRB assay is based on the ability of the anionic aminoxanthene dye 
Sulforhodamine B (Acid Red 52) to bind and form electrostatic complexes with the 
basic amino acid residues of trichloroacetic acid-fixed cells in a pH-dependent 
manner. Under mild acidic conditions, it binds to the fixed cellular protein, while 
under mild basic, conditions it can be extracted from cells and solubilized for 
measurement. The SRB Assay was performed at the Council for Scientific and 
Industrial Research (CSIR) in Pretoria, South Africa in accordance with the protocol 
as developed in the frame work of the collaborative research programme between 
the CSIR and the Drug Evaluation Branch of the National Cancer Institute (NCI). 
The cancer cell lines TK10, UACC62 and MCF7 were obtained from NCI and were 
routinely maintained as a monolayer cell culture at 37ºC, 5% CO2, 95% air and 
100% relative humidity in RPMI containing 5% foetal bovine serum, 2 mM L-
glutamine and 50 µg/ml gentamicin. The normal Human Foetal Lung Fibroblast - 
WI-38 cell line; from the European Collection of Cell Cultures (ECACC) was 
routinely maintained as a monolayer cell culture at 37ºC, 5% CO2, 95% air and 
100% relative humidity in Eagles’ minimum EMEM containing 10% foetal bovine 
serum, 2 mM L-glutamine and 50 µg/ml gentamicin. 
The dry material from each extract was then re-dissolved in dimethyl sulphoxide 
(DMSO) and diluted to produce five concentrations ranging from 0.01-100 µg/ml. 
To carry out the screening experiments, 3 -19 passages of the cells (for the 
anticancer activity screening) and 21-50 passages of the cells (for the cytotoxicity 
screening) were inoculated in a 96-well microtiter plates at plating densities of 7-
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10 000 cells per well and were incubated at 35ºC for 24 hours. Following 
incubation, the cells were treated with different concentrations of the re-dissolved 
plant extracts. Controls were prepared with cells without the plant extracts. The 
blank contained complete medium without cells. Parthenolide was used as a 
standard (because of its known anticancer properties) at concentrations of 0.01-
100 µg/ml. For the cytotoxicity experiment; Emetine was used as a standard, at 
concentrations of 100 – 1.0 x10-2 µg/ml. 
After addition of the extracts, the plates were further incubated for 48 hours and 
cold 50% trichloroacetic acid was added to fix viable cells to the bottom of each 
well. The plates were then washed, air-dried and dyed by SRB solution. Unbound 
dye was removed and 10 mM Tris base was used to extract protein-bound dye for 
optical density determination using a multiwell spectrophotometer. This determined 
the net cell growth percentage. The assays were done in triplicate. 
 
2.2.3. Statistical analysis: 
Data analysis was performed using GraphPad Prism software. The cell growth 
inhibition activities and cytotoxic effects of the plant extracts are reported as IC50 
values and were divided into four categories (Table 2.1). Non-linear regression was 
used to determine the IC50. 
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cell lines is more than 100 µg/ml. Therefore, the aqueous and the methanol 
extracts of Gnidia polycephala were inactive when tested against TK10 and MCF7 
cancer cell lines. Similarly, the aqueous extracts of Senecio serratuloides were 
inactive when tested against TK10, UACC62 and MCF7 cancer cell lines. 
An extract with an IC50 value greater than 15 µg/ml but less than 100µg/ml when 
tested against two or more cell lines is considered weak (Table 2.1). The acetone 
extracts of Gnidia polycephala as well as both the acetone and methanol extracts 
of Senecio serratuloides were weak against TK10, UACC62 and MCF7 cancer cell 
lines. The standard drug (Parthenolide) had potent anticancer activity with IC50 
values of less than 6.25 µg/ml for all three cell lines. 
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This is the first record worldwide, of the anticancer activity screening for both 
Gnidia polycephala and Senecio serratuloides. Gnidia species are commonly used 
as medicine to treat abdominal pains, sore throats, wounds, burns and snakebites 
(Franke et al., 2002). According to the review of literature, species in this Genus 
are not known for their anticancer activities (Bhandurge et al., 2013). This is 
explained by the weak and inactivity of G. polycephala against the tested cancer 
lines in this study. Plants in the Senecio genus are known to possess compounds 
such as PAs, senecionine and senecionine-N-oxide which were previously 
reported to have anti-tumor, antispasmodic and inflammatory properties (Fawole 
et al., 2012). However, these were not detected in the current study. 
Active compounds isolated in their pure form have proven to have higher activities 
than the crude compounds (Magama et al., 2003; Suleiman et al., 2012; Yessoufou 
et al., 2015). Parthenolide had potent anticancer activity in the experimental 
conditions of this study while the tested crude plant extracts had weak or inactive 
anticancer activity. Fractions of the plant extracts or pure compounds instead of 
crude preparations should be further tested for anticancer activity and perhaps 
greater anticancer activity may be observed especially from the acetone extracts 
from both plants and the methanol extracts from S. serratuloides. However, further 
investigations are only feasible for those extracts that show potent activity (IC50s of 
less than 6.25 µl/ml) (Fouche et al., 2008). Additionally, it is known that different 
cell lines exhibit different sensitivities towards different compounds as contained 
by different plant extracts (Kamuhabwa et al., 2000). Further screening of G. 
polycephala and S. serratuloides extracts against more cell lines may show 
different inhibitory activities. 
According to CSIR criteria (Table 2.1), an extract is a low hazard if the IC50 value 
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is more than 100 µg/ml. Consequently, the acetone and the methanol extracts of 
Gnidia polycephala as well as the aqueous and methanol extracts of Senecio 
serratuloides were low hazards and can be considered relatively safe. The 
aqueous extract of Gnidia polycephala and the acetone extracts of Senecio 
serratuloides can be classified as weak hazards with IC50 values of between 30 
µl/ml and 100 µl/ml respectively. All extracts were relatively safer than the standard 
Emetine. 
The selectivity of the anticancer activity of Gnidia polycephala and Senecio 
serratuloides extracts was determined by comparing the anticancer activity (IC50) 
of each plant extract against each cancerous cell with that of the normal human 
fetal lung fibroblast cell line (Table 2.2). The SI of greater than 3 was considered 
as highly selective. As a result, the acetone extract of Gnidia polycephala 
demonstrated higher selectivity for the TK10 and UACC62 cell lines. Similarly, the 
acetone extract of Senecio serratuloides demonstrated higher selectivity for 
UACC62 cells, while the methanol extract of Senecio serratuloides demonstrated 
higher selectivity for all cell lines used in this study. Extracts that demonstrate 
higher selectivity offer the potential of safer therapy. A low SI indicates that the 
anticancer activity is probably due to cytotoxicity rather than activity of the tested 
extracts against the cancer cell lines themselves (Valdẻs et al., 2010). 
 
2.4. Conclusion 
The extracts from Gnidia polycephala and Senecio serratuloides were generally 
inactive or weak. Despite the potential of improving anticancer activity from the 
isolation of pure compounds, we do not recommend these extracts as possible 
leads in the development of new anticancer agents. Since some of the tested 
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extracts demonstrated higher selectivity for cancer cells and have proved to be 
relatively safe, we warrant the use of Gnidia polycephala and Senecio 
serratuloides in ethno-medicine. 
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CHAPTER 3 
ANTIDIABETIC EFFECTS OF EXTRACTS FROM GNIDIA POLYCEPHALA 
AND SENECIO SERRATULOIDES 
3.1. Introduction 
The beta (β)-pancreatic cells of the islet of Langerhans synthesize insulin; which 
is the hormone responsible for controlling the body’s blood glucose levels by 
enhancing membrane transport of glucose; inhibiting the breakdown of glycogen 
to glucose; and inhibiting the conversion of amino acids or fats to glucose (Marieb 
and Hoehn, 2014; Olabanji et al., 2014). Diabetes mellitus is defined as a metabolic 
disease associated with high levels of blood glucose- hyperglycemia, due to 
defects in insulin secretion, insulin action, or both (Olabanji et al., 2014) or 
insensitivity of target organs to insulin (Mahendran et al., 2014). When insulin 
production or secretion is insufficient, the resulting type is type I diabetes mellitus; 
whereas; when insulin secretion is sufficient, but its effects are deficient, the 
resulting type is type II diabetes mellitus (Marieb and Hoehn, 2014; Yang et 
al.,2015). 
In 2013, the International Diabetes Federation (IDF, 2013) reported that the 
number of people living with diabetes had reached 382 million. Another 316 million 
people were found to have impaired glucose tolerance and were at a higher risk of 
developing the disease. Furthermore, by December 2013, diabetes had killed 5.1 
million people which is more deaths than those caused by HIV/AIDS (1.5 million), 
TB (1.5 million) and Malaria (0.6 million) combined (IDF, 2015). According to a 
recent report of the IDF; there are now more than 500 000 children aged 14 years 
and younger who are living with type I diabetes. The number of adults aged 20 - 
79 living with diabetes has also increased from 258 million in 2010 (Trinh et al., 
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2016) to 415 million worldwide; with 318 million adults now found to have impaired 
glucose tolerance. The number of people living with this disease is now expected 
to rise to 642 million by the year 2040 (IDF, 2015). The increase in the prevalence 
of diabetes mellitus may be attributed to factors including excessive body weight, 
dietary changes due to urbanization, and physical inactivity (Shinkafi et al., 2015; 
Yang et al., 2015). In particular, type II diabetes together with its associated 
complications has placed serious economic and health burdens on societies 
across the world (Yang et al., 2015). 
The deficiency in insulin action leads to abnormalities of carbohydrate, lipid, and 
protein metabolism (Mahendran et al., 2014). Diabetes mellitus, and in particular 
type II diabetes; can cause complications like renal failure, cardiovascular disease, 
blindness or other liver diseases (Barapatre et al., 2015; Yang et al., 2015). 
Similarly, epidemiological research into the causes and effects of diabetes mellitus 
has shown an association between diabetes and the incidence and mortality as a 
result of cancer. Increased cancer risk in type II diabetes refers to liver, pancreatic, 
colorectal, kidney, endometrial and breast cancer (Tokajuk et al., 2015). 
Correct glycemic control measures are the best possible prevention strategy that 
delays the progression of the disease and the development of the often associated 
complications (Tokajuk et al., 2015). The most recently adopted therapeutic 
measure for treating diabetes mellitus is to decrease the post-prandial 
hyperglycemia. This is achieved by retarding the absorption of glucose through the 
inhibition of the carbohydrate-hydrolyzing enzymes, α-amylase and α-glucosidase, 
in the gastrointestinal system. Inhibitors of these enzymes delay carbohydrate 
digestion time, resulting in a reduction in the rate of glucose absorption and 
consequently blunting the post-prandial plasma glucose increase (Ali et al., 2006; 
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Narkhede et al., 2011). As a consequence, more research efforts are now focused 
on the search for more effective and safe inhibitors of α-amylase and α-glucosidase 
from naturally occurring products to develop physiological functional food to treat 
diabetes mellitus (Wang et al., 2010). 
Hypoglycemic drugs are mostly used as monotherapy or in combinations to yield 
better glycemic regulation. These include insulin and insulin analogs, insulin 
secretagogues (such as sulfonylureas, meglitinides, GLP-1 agonists, DPP-4 
inhibitors), insulin sensitizers (such as biguanides, thiazolidinediones), and other 
drugs with different mechanisms of action (such as α-glucosidase inhibitors, 
SGLT2 inhibitors) (Tokajuk et al., 2015; Yang et al., 2015). However, most of the 
anti-hyperglycemia agents currently in use, like acarbose and metformin are 
synthetic (McCue et al., 2004). These synthetic drugs are associated with high 
costs of production and severe and adverse side effects at high doses which limits 
their use (Mahendran et al., 2014; Tokajuk et al., 2015). Furthermore, a number of 
these synthetic drugs are losing efficacy in treating this condition, showing drug 
resistance (Yang et al., 2015). 
Medicinal plants exert an effect on blood glucose through different mechanisms. 
For instance, some of them may possess insulin kinase, while some may inhibit 
insulinase activity, and others may increase the reconstruction of the pancreatic β 
cells (Bahmani et al., 2014). The medicinal effects and efficacy of these plants may 
be attributed to the presence of various active phytochemicals (Shinkafi et al., 
2015) such as flavonoids which have the ability to prevent the progressive 
impairment of pancreatic beta-cell function as a result of oxidative stress. As a 
result; flavonoids may reduce the occurrence of type II diabetes (Bhandari et al., 
2008). Furthermore, the flavonoid; quercetin, is a glycation inhibitor and can 
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stimulate insulin secretion. Some alkaloids (casuarine 6-0-alpha-glucoside) and 
phenolics (7’-(3’, 4’-Dihydroxyphenyl)-N-[(4 methoxyphenyl) ethyl] propenamide, 
7’-(4’-hydroxy-3’methoxyphenyl)-N-[(4butylphenyl) ethyl] propenamide) are known 
to inhibit α-glucosidase activity (Bahmani et al., 2014). These phytochemicals are 
associated with low side-effects and low costs of production, and therefore open 
new avenues to explore for the treatment various diseases including diabetes 
mellitus (Mahendran et al., 2014). This chapter explores the antidiabetic effects of 
extracts from G. polycephala and S. serratuloides in support of the search for novel 
antidiabetic drug leads. 
 
3.2. Methods 
The identification, collection, and preparation of the extracts from Gnidia 
polycephala and Senecio serratuloides was performed as previously described in 
Chapter 2 (section 2.2.1). In the next step, the aqueous extracts were re-dissolved 
in distilled water and both the acetone and methanol extracts were re-dissolved in 
10% ethanol. 
 
3.2.1. α-Amylase inhibition assay 
The antidiabetic effects of extracts from G. polycephala and S. serratuloides were 
evaluated using the α-amylase inhibition assay adopted from Narkhede et al., 
(2011) and Sabitha et al., (2012) with slight modifications. 
In different test tubes; 30 µl of each of the different plant extracts and 10 µl of 20 
mM phosphate buffer (pH 6.9) were added to 20 µl human salivary α-amylase (1 
mg/ml); and incubated in a water bath at 37⁰C for 30 minutes. Afterwards, 90 µl of 
a 1% soluble starch was added to each test tube, to act as a substrate for the 
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reaction, and incubated further at 37ºC for 20 minutes. Then the reaction was 
stopped with the addition of 50 µl DNS colour reagent (1% 3, 5-dinitrosalicylic acid 
and 12% potassium sodium tartrate (S6170) in 0.4 M NaOH), and heated in a 
boiling water bath for 5 minutes, and allowed to cool down to room temperature. 
The reaction mixture was then diluted with 500 µl distilled water in an ice bath. All 
the tests were performed in triplicate at a final concentration of 200 µg/ml (which 
would have been reduced in the subsequent experiments if there was potent 
antidiabetic activity at 200 µg/ml). 
The control tubes were prepared with 40 µl phosphate buffer and 20 µl α-amylase. 
The blank was prepared with 60 µl of phosphate buffer without the enzyme and 
the inhibitor tubes with 10 µl phosphate buffer, 20 µl α-amylase and 30 µl acarbose 
(1 mg/ml) or α-amylase inhibitor from wheat seed (1 mg/ml). The solvent control 
tubes were prepared with 10 µl phosphate buffer, 20 µl α-amylase and 30 µl solvent 
(10% ethanol). 
The extracts that showed inhibition on α-amylase were recognized by a pale brown 
colour as compared to the control or no colour change, which in turn determines 
the extent of inhibition. The contents in the tubes were then transferred to the 
respective wells in a 48 well plate. The absorbance was measured at 540 nm on a 
Tecan-Infinite 500 multiwell spectrophotometer (Tecan Group Ltd., Switzerland). 
The results were expressed as percentage inhibition which was calculated using 
the formula: 
%Inhibition= 𝐴𝐴540 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶−𝐴𝐴540 𝐶𝐶𝑡𝑡𝑡𝑡𝐶𝐶 𝑡𝑡𝑠𝑠𝑠𝑠𝑠𝑠𝐶𝐶𝑡𝑡
𝐴𝐴540 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 × 100 
 
3.2.2. α-Glucosidase inhibition assay 
The extracts from G. polycephala and S. serratuloides were also evaluated using 
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the α-glucosidase inhibition assay (Narkhede et al., 2011). In a 96 well plate; 20 µl 
of each of the different plant extracts were added to 10 µl phosphate buffer and 10 
µl α-glucosidase (from Saccharomyces cerevisiae). Since the extracts had 
pigments which might interfere with the assay, extract controls were prepared with 
80 µl phosphate buffer and 20 µl of the extract. The other control wells were 
prepared with 30 µl 20 mM phosphate buffer (pH 6.9) and 10 µl α-glucosidase (100 
µg/ml). The blank was prepared with 40 µl of phosphate buffer without the enzyme 
and the inhibitor wells with 20 µl dimethoxymethylamphetamine (DMMA) (1 
mg/ml), 10 µl phosphate buffer and 10 µl α-glucosidase. 
The plate was incubated at 37°C for 30 minutes. Sixty microliters of (1%) soluble 
starch was added to each well and the plate incubated further for 15 minutes. All 
samples were done in triplicate at a final concentration of 200 µg/ml (which would 
have been reduced in the subsequent experiments if there was potent antidiabetic 
activity at 200 µg/ml). The absorbance was measured at 405 nm on a Tecan micro-
plate reader (Tecan Group Ltd., Switzerland). The results were expressed as 
percentage inhibition which was calculated as follows: 
%Inhibition= 𝐴𝐴405 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶−𝐴𝐴405 𝐶𝐶𝑡𝑡𝑡𝑡𝐶𝐶 𝑡𝑡𝑠𝑠𝑠𝑠𝑠𝑠𝐶𝐶𝑡𝑡
𝐴𝐴405 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 × 100 
 
3.3. Results and discussion 
A total of six extracts from Gnidia polycephala and Senecio serratuloides were 
assessed for inhibitory activity against α-amylase and α-glucosidase, and the 
results are presented as Table 3.1. G. polycephala showed more antidiabetic 
potential than S. serratuloides. The acetone extract from G. polycephala showed 
the highest anti-α-amylase activity at 66.34 ± 0.84% inhibition in comparison to all 
other G. polycephala and S. serratuloides extracts which had anti-α-amylase 
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inhibition of less than 10%. Acetone extract from G. polycephala had the highest 
anti-α-glucosidase activity at 81.75 ± 0.86%; followed by the acetone extracts from 
S. serratuloides with 78.86 ± 1.10% inhibition. The aqueous (54.84 ± 0.65%) and 
methanol (45.43 ± 0.56%) extracts of G. polycephala had higher inhibitory effects 
than those of S. serratuloides. Although, the inhibitory potency of these extracts 
were still lower than that of acarbose (92.10 ± 0.91%); α-amylase inhibitor (91.12 
± 1.19%) and dimethoxymethylamphetamine (DMMA) (100.16 ± 0.011%), the 
observed results (Table 3.1) clearly demonstrate the potential of these crude 
extracts as inhibitors of α-amylase and α-glucosidase enzymes. The solvent 
control, 10% EtOH showed low effect on both the α-amylase (6.05 ± 0.086%) and 
on the α-glucosidase (7.70 ± 0.65%). This effect was subtracted from that of all 
extracts except for the aqueous extracts, to correct for the % inhibition due to the 
solvent. 
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Table 3.1: α-amylase and α-glucosidase inhibition by G. polycephala and S. 
serratuloides extracts 
 
1: distilled water, 2: methanol, 3: ethanol, 4: dimethoxymethylamphetamine 
The inhibitory effects of the tested extracts could be enhanced by adopting 
preparation techniques similar to those used in ethnomedicine. For instance, most 
of the medicinal plants used to treat diabetes are prepared in ethnomedicine as 
infusion or decoctions. Boiling the plant material in water to prepare these infusions 
 
Extract 
% Inhibition ± SD 
α-Amylase Assay α-Glucosidase Assay 
 
G
.p
ol
yc
ep
ha
la
 
dH2O1 -11.79 54.84 ± 0.65 
Acetone 66.34 ± 0.84 81.75 ± 0.86 
MeOH2 10.81 ± 1.32 45.43 ± 0.56 
 
S.
se
rr
at
ul
oi
de
s 
dH2O -0.60 28.44 ± 1.98 
Acetone 9.71 ± 0.019 78.86 ± 1.10 
MeOH 6.59 ± 0.10 22.95 ± 1.50 
 
C
on
tr
ol
s 
10%EtOH3 6.05 ± 0.086 7.70 ± 0.65 
Acarbose 92.10 ± 0.91 - 
α-amylase inhibitor 91.12 ± 1.19 - 
DMMA4 - 100.16 ± 0.011 
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and decoctions extracts could yield more active compounds from the plants 
(Ezuruike and Prieto, 2014; Cruz and Andrade-Cetto, 2015). As a result, infusions 
and decoctions possess high concentrations of active compounds. The nature of 
compounds within medicinal plants is complex. This suggests that they exert their 
therapeutic effects either as single compounds or act synergistically and increase 
each other’s efficiency. They can also antagonise the therapeutic effect of an 
otherwise bioactive compound (Komape et al., 2017). 
 
3.4. Conclusion 
The Gnidia polycephala extracts showed higher α-amylase and α-glucosidase 
enzymes inhibitory activities than the extracts from S. serratuloides. We 
recommend further in vitro experiments to ascertain the mechanism of action from 
the extracts with high α-amylase and α-glucosidase enzymes inhibitory activities 
as well as to determine if the inhibition is as a result of the compounds acting 
synergistically or individually. These extracts could be potentially developed as 
anti-diabetic drugs. 
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CHAPTER 4 
ANTIMICROBIAL ACTIVITY OF EXTRACTS FROM GNIDIA POLYCEPHALA 
AND SENECIO SERRATULOIDES 
4.1. Introduction 
The well-being of humankind is seriously under threat following the emergence of 
resistant pathogens (Komape et al., 2017). The emergence of bacterial resistance 
to the currently available antibiotics is often attributed to the indiscriminate use of 
antibiotics and the development of new bacterial strains which cause diseases 
(Khan et al., 2014). Antibiotics such as quinolones, carbapenems and 
cephalosponins have become ineffective following the emergence of anti-microbial 
resistance (Ahmed et al., 2012; Roca et al., 2015). Consequently, antibiotic 
resistance has become an enormous therapeutic challenge and thus infections 
have greatly increased globally (Elisha al., 2017). Over 70% of pathogens seen in 
hospitals in the United States of America have now developed resistance to at least 
one antibiotic which has led to the rate at which people die from infections acquired 
in hospital exceeding 14 000 patients per year (Khanam et al., 2015). This problem 
is not only persistent in the United States of America, but has become a worldwide 
phenomenon (Ahmad and Beg, 2001). 
The most important emerging cases of antimicrobial resistance include; the 
resistance of oxacillin by staphylococci, penicillin resistance in streptococci, 
vancomycin resistance in enterococci (and eventually staphylococci), resistance 
to extended-spectrum cephalosporins and fluoroquinolones in members of 
enterobacteriaceae, and carbapenem resistance in Pseudomonas aeruginosa 
(Ahmed et al., 2012). Furthermore, opportunistic and enteropathogenic bacteria 
have been identified as causes of serious diseases. For example, Pseudomonas 
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aeruginosa is implicated in infections of the respiratory system as well as other 
systemic infections. Staphylococcus aureus has been associated with skin 
infections and sepsis of wounds (Ahmed et al., 2014). According to the World 
Health organization (WHO, 2012), infectious (including parasitic) diseases were 
together responsible for the deaths of more than 8.7 million people worldwide in 
2008. 
From ancient times, traditionally used medicinal plants have always been an 
abundant source of antimicrobial agents (Khanam et al., 2015). Plant derived 
antimicrobials have immense therapeutic potential and can effectively be used in 
the treatment of infectious ailments (Kokoska et al., 2002). This is because plants 
have developed various defense responses against most microbial pathogens. 
These include the production of small molecular mass peptides called antimicrobial 
peptides (Khanam et al., 2015) which are grouped into the following families: 
thionins, defensins, cyclotides, lipid transfer proteins and hevein-like proteins 
(Nawrot et al., 2013). Phytochemicals from medicinal plants may also have a 
different mechanism of action from that of conventional antimicrobial agents 
(Mothana and Lindequist, 2005). This explains the extensive use of plant extracts 
to treat most infectious diseases throughout the history of mankind and why this 
continues as part of the primary healthcare especially in developing countries 
(Magama et al., 2003). 
As an alternative, medicinal plants are important in the discovery and consequent 
development of novel antimicrobial metabolites to solve the issue of antimicrobial 
resistance to the currently available drugs (Mickymaray et al., 2016). 
Subsequently, the attention of researchers across the globe is now focused on 
traditional medicine, searching for leads to the discovery of new drugs for the 
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treatment of microbial infections (Srinivasan et al., 2001). 
South Africa has one of the richest flora in the world; with about 19 581 indigenous 
species, but only approximately 3 000 species are used as medicines (Nielsen et 
al., 2012), and the rest are still to be evaluated medicinally. The evaluation and 
subsequent documentation of medicinal plants should be seen and treated as an 
important matter (Srinivasan et al., 2001). 
The majority of the current synthetic drugs are manufactured from herbal 
medicines. It is estimated that no less than 119 compounds of plant origin are 
currently used as important clinical drugs (Khan et al., 2014). There is an increased 
use of plants in the treatment of bacterial infections as compared to synthetic 
antibiotics because plants are believed to be safe and are easily accessible and 
generally affordable. Thus, the popularity of plant remedies has increased in 
comparison to the synthetic drugs (Bahmani et al., 2015). 
The purpose of this study was to evaluate the antimicrobial potential of Gnidia 
polycephala and Senecio serratuloides. Gnidia polycephala is used to treat 
tuberculosis, tonsillitis and wounds (Munkombwe et al., 2003). Senecio 
serratuloides is applied in the treatment of chest pains and skin eruptions, sores 
and cuts (van Wyk et al., 2009; Fawole et al., 2010). These traditional uses of the 
plants suggest that they may have antimicrobial properties. 
 
4.2. Methods 
4.2.1. Preparation of plant material 
The plant extracts from Gnidia polycephala and Senecio serratuloides were 
prepared as outlined in Chapter 2 (section 2.2.1). The dried extracts were then re-
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dissolved separately on a vortex shaker in 2% acetone, 2% methanol and distilled 
water to give a final concentration of 10 mg/ml as a stock solution. Thereafter, each 
plant extract was serially diluted two-fold into concentrations of 5 mg/ml, 2.5 mg/ml, 
1.25 mg/ml, 0.625 mg/ml and 0.3125 mg/ml. Thus, for the experiment, the 
concentrations used ranged from 0.3125 to 10 mg/ml. Acetone and methanol were 
both used as solvents of extraction due to their ability to completely dissolve the 
extracts and because of their non-inhibitory effect on the organisms at 2% (Meyer 
and Afolayan, 1995; Madamombe and Afolayan, 2003). 
 
4.2.2. Microorganisms 
The bacterial species used in this investigation were supplied by the Department 
of Health Sciences of the Central University of Technology, Free State in 
Bloemfontein. The Gram positive bacteria used were Staphylococcus aureus 
(ATCC 11632), Staphylococcus epidermis (ATCC 12228) and Bacillus subtilis 
(ATCC 11774). Gram negative bacteria included Proteus vulgaris (ATCC 6380), 
Pseudomonas aeruginosa (ATCC 10145), Klebsiella pneumonia (ATCC 10031), 
Enterobacter cloacae (ATCC 13047) and Escherichia coli (ATCC 13762). Pure 
cultures of each organism were streaked and maintained on Mueller-Hinton (MH) 
agar plates (Oxoid) and incubated at 37°C for 24 hours. Isolated colonies were 
aseptically inoculated in fresh sterile MH broth (Sigma) and incubated for a further 
24 hours (Khanam et al., 2015). 
 
4.2.3. Antimicrobial activity screening 
The microdilution assay was performed as prescribed by Eloff (1998); Aremu et al., 
(2010) and Suleiman et al., (2012), with slight modifications. Hundred microliters 
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of the diluted extracts were then added to a 96-well microtiter plate. The positive 
controls were prepared with 100 µl of chloramphenicol at 1mg/ml. The negative 
control only contained MH broth; prepared to ensure that there was no bacterial 
growth other than that of the inoculated bacteria. The other controls were the wells 
with each tested bacterial culture with MH broth, and the wells prepared with the 
solvent of extraction (2% acetone, 2% methanol and dH2O) to ensure that the 
solvents of extraction did not inhibit bacterial growth. 
One millilitre of overnight bacterial cultures previously grown in MH broth at 37°C 
(Section 4.2.2) was diluted with 100 ml fresh sterile MH broth (1:100 dilution) and 
100 µl was added to the treatment wells and incubated for 24 hours at 37°C. 
Thereafter, 40 µl of p-iodonitrotetrazolium violet [INT] (Sigma) at a concentration 
of 0.2mg/ml was added to each of the microtitre wells to indicate bacterial growth 
by formazan formation in the presence of bacteria. The microtiter plate was then 
incubated for 30 minutes at 37°C and the Minimum inhibitory concentration (MIC) 
values were recorded as the lowest concentrations at which no bacterial growth 
occurred. The assay was performed in triplicate. 
 
4.3. Results and discussion 
The extracts from Gnidia polycephala and Senecio serratuloides were not active 
against most of the tested bacterial species at the concentrations used in this study. 
This was shown by the violet colour change in the wells of the microtiter plate 
where bacterial growth occurred (Fig 4.1). The inactivity of most antimicrobial 
drugs against most bacteria may be a result of the presence of the 
lipopolysaccharide in the outer membrane of gram negative bacteria. This 
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membrane presents a permeability barrier and hampers diffusion of antibiotic 
molecules. Consequently; gram negative bacteria are found to be relatively 
resistant to plant extracts (Suleiman et al., 2012; Khanam et al., 2015). 
The methanol and acetone extracts of both Gnidia polycephala and Senecio 
serratuloides showed some antibacterial activity on only one bacterial species. S. 
aureus was susceptible to G. polycephala at 10 mg/ml and to S. serratuloides at 5 
mg/ml. Generally, crude extracts acquired by extracting plant material with 
methanol have previously proved to have high success rates with regards to the 
variety of phytochemicals as compared with water (Magama et al., 2003). Water 
extracts from several plant species barely have antimicrobial activity (Dzoyem et 
al., 2016) because water is not effective in extracting antimicrobial compounds 
from plants (Makhafola and Eloff, 2012). This may explain the inactivity of the water 
extracts of both Gnidia polycephala and Senecio serratuloides against the tested 
bacteria. Furthermore, acetone has also been found to be the best solvent of 
extraction for most plant species when investigating their antimicrobial activity 
(Makhafola and Eloff, 2012; Dzoyem et al., 2016) primarily because of its ability to 
extract a wide variety of compounds with different polarities (Elisha et al., 2017). 
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Fig .4.1: 96 well microtiter plates inoculated with S. aureus, G. polycephala (A, B, 
C), S. serratuloides (D, E, F) and controls before addition of INT (left) and after 
addition of INT (right) 
 
The lack of bactericidal activity of extracts from Gnidia polycephala and Senecio 
serratuloides against the bacteria used in this study may be explained by the 
findings of Aderogba et al., (2012) who postulate various mechanisms of action by 
plant extracts in treating microbial infections. Plant extracts can either have a direct 
or an indirect effect. A direct effect implicates the action of the active agents; 
whereas the indirect effect implicates the stimulation of the host’s immune system 
to overcome the effects of microorganism. Sakarkar and Deshmukh (2011) 
suggest that certain medicinal plants by themselves may not be potent enough to 
achieve the desired therapeutic effects, but may help improve the body’s own 
immunity towards diseases, and in this way be useful in the treatment and 
management of infectious diseases. In addition, it may be necessary to transform 
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compounds within medicinal plants with metabolic systems of the body to activate 
therapeutic components within them. This has been observed in several traditional 
medicinal plants such as Senna alexandrina (Senna) which has laxative effects. In 
this case, the intestinal flora hydrolyses the glycosides to release the aglycones 
which in turn cause alterations in the water permeability of the walls of the 
gastrointestinal tract and enhances peristalsis, and in this way the plant imposes 
its laxative effects (Houghton et al., 2007). 
Furthermore, the ethnomedical uses of these medicinal plants in the traditional 
medicine systems can also provide a possible explanation for the lack of 
bactericidal activity found in our laboratory investigations. For instance, in 
traditional medicine, G. polycephala is used to stabilize heart conditions, treat 
tuberculosis, tonsillitis, and wounds (Munkombwe et al., 2003). The medicinal 
effects of G. polycephala in these instances, may not be attributed to its ability to 
inhibit the investigated bacteria. Moreover, the inactivity of the investigated plant 
extracts may be attributed to the plant parts investigated as opposed to the parts 
used in traditional medicine. According to van Wyk et al., (2009) the leaves of S. 
serratuloides are applied over cuts, swellings, burns and sores to encourage 
healing. The leaves are also dried then crushed into fine powder and snuffed to 
treat headaches. Small dosages of the plant teas are drank to purify blood for skin 
eruptions or swollen gums and chest pains, however, this study screened stem 
extracts and not the leaves of the plant. 
The use of the microdilution method to determine the minimum inhibitory 
concentration (MIC) of the plant extracts against the selected bacteria may have 
been a methodological shortcoming in this study. The MIC was determined visually 
as the lowest concentration that led to growth inhibition. Perhaps, this approach is 
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better suited to determine the minimum bactericidal concentration (MBC) instead 
of the MIC, which could most accurately be determined calorimetrically by using a 
multiwell spectrophotometer. 
Finally, because chloramphenicol was active against all tested bacterial species 
and the tested crude plant extracts were inactive in our experimental setup, we 
recommend further antimicrobial investigations from fractions of the plant extracts 
instead of crude preparations. This is also because active compounds isolated in 
their pure form have proven to have higher activities than the crude compounds 
(Magama et al., 2003; Suleiman et al., 2012; Yessoufou et al., 2015). 
 
4.4. Conclusion 
The investigated plant extracts were inactive against most of the tested bacteria 
except for the acetone and methanol extracts of both G. polycephala and S. 
serratuloides against S. aureus. The results of this study do not validate the use of 
G. polycephala and S. serratuloides as direct antimicrobial agents, and do not 
support the use of these plants as possible leads for new antimicrobial drug 
development. 
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CHAPTER 5 
PHYTOCHEMICAL PROPERTIES OF EXTRACTS FROM GNIDIA 
POLYCEPHALA AND SENECIO SERRATULOIDES 
5.1. Introduction 
Nature has provided generations of humans with medicinal agents for centuries 
(Dadsena et al., 2013). Medicinal plants have since remained the principal 
constituent of traditional medical systems and still serve as an inexhaustible source 
of alternative medicines for the treatment and management of various human 
ailments (Fuku et al., 2013). It is estimated that 80% of the total world population 
relies on traditional medicine which comprises primarily of compounds of plant 
origin (Alabri et al., 2014). 
Plants have phytochemical constituents that participate in all biochemical 
processes, such as growth, development, and reproduction as well as in the 
interactions of the plant with both its biotic and abiotic environments (Islam et al., 
2015). Phytochemicals are grouped into two groups based on their roles in plant 
metabolism, that are primary and secondary metabolites (Bhumi and 
Savithramma, 2014; Dias et al., 2015). Primary metabolites include amino acids, 
carbohydrates and proteins, whereas secondary metabolites comprise of the 
alkaloids, flavonoids, saponins, steroids, tannins amongst others (Bhumi and 
Savithramma, 2014; Rehana Banu and Nagarajan, 2014). Plants produce 
secondary metabolites mainly to aid their defense against predation by 
microorganisms, herbivores and insects. Furthermore, terpenoids are involved in 
plant odor, tannins and quinines are involved in pigmentation, whereas capsacins 
are involved in flavour. They also function in pollination by attracting pollinators and 
symbionts, and also respond to abiotic stresses (Dadsena et al., 2013; Fuku et al., 
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2013). The therapeutic potential of medicinal plants lies in the phytochemical 
constituents that cause certain medicinal and pharmacological actions in human 
beings (Behere and Boru 2014; Rehana Banu and Nagarajan, 2014; Islam et al., 
2015). 
In recent years, alternative medicine has increasingly become popular, and it is 
estimated that 44% of all newly developed drugs are derived from natural products 
(Suleiman et al., 2010) and play a crucial role in the pharmaceutical industry with 
regards to drug development programmes (De et al., 2010). In the discovery and 
consequent development of any novel plant-derived drug with pharmacological 
significance, preliminary information is generally provided by qualitative 
phytochemical screening. Qualitative phytochemical screening of plant extracts 
gives information regarding the presence of clinically important constituents. In the 
event that the plant contains important bioactive constituents, these may be 
isolated from the mixture of compounds by using chromatographic techniques best 
suited for this purpose (Jayashree, 2013). A number of phytochemicals with 
therapeutic effects have been isolated from medicinal plants. These include 
vincristine, vinblastine and curcumin which are anticancer phytochemicals (Oh et 
al., 2016), roseoside, glycyrrhetinic acid and strictinin which have anti-diabetic 
properties (Ogundele et al., 2017) as well as thymol, eugonol and carvacrol which 
are antimicrobials (El-Zawahry et al., 2013). 
It is against this background that this chapter focused on determining the 
phytochemical composition of the extracts from Gnidia polycephala and Senecio 
serratuloides. 
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5.2. Methods 
5.2.1. Qualitative phytochemical screening of extracts from Gnidia 
polycephala and Senecio serratuloides 
The phytochemical analysis of Gnidia polycephala and Senecio serratuloides was 
carried out using different qualitative methods adapted from Iqbal et al., (2015) and 
Sharma et al., (2012). Specifically, the plant material was screened for the 
presence of alkaloids, flavonoids, saponins and tannins because of their 
importance for the current study. Flavonoids and tannins are associated with 
anticancer properties, alkaloids, flavonoids and saponins have antidiabetic 
activities and alkaloids, saponins, and tannins are antimicrobials (Aremu et al., 
2010; Bahmani et al., 2014; Elekofehinti et al., 2015; Iqbal et al., 2015). 
 
5.2.1.1. Alkaloids (Dragendorff’s test) 
About 15mg of plant material was separately boiled with 6ml of 1% HCl on a water 
bath for five minutes and filtered. To 1 ml of the filtrate, two drops of the 
Dragendorff’s reagent (Potassium bismuth iodide solution) were added. The 
presence of alkaloids is detected by the reddish brown precipitate (Sharma et al., 
2012; Iqbal et al., 2015). 
 
5.2.1.2. Flavonoids 
To determine the presence of flavonoids, 200mg of the plant material was 
dissolved in diluted NaOH and then HCl was added to it, then observed for a colour 
change (Sharma et al., 2012). 
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5.2.1.3. Saponins 
The presence of saponins from the plant material was detected by boiling 100mg 
in 5mL dH2O and shaking vigorously 1ml of the filtrate and observed for froth 
formation. The presence of saponins is indicated by froth which persists on 
warming in a water bath for five minutes (Sharma et al., 2012; Iqbal et al., 2015). 
 
5.2.1.4. Tannins 
To detect the presence of tannins, 200mg powdered plant material was boiled in 
10mL dH2O, filtered and 2ml of the filtrate treated with 2mL of FeCl3 solution and 
observed for a colour change. The presence of tannins is indicated by formation of 
a precipitate or black or blue-green colour change (Sharma et al., 2012; Iqbal et 
al., 2015). 
 
5.2.2. Gas Chromatography-Mass Spectrometry (GC-MS) 
GC-MS analysis was carried out at the Central Analytical Facilities (CAF) at the 
Stellenbosch University, Stellenbosch. Five milligrams of dried plant extracts were 
re-suspended in 2ml ethyl acetate with vortexing and sonication to assist 
dissolution of the active compounds. The samples were then centrifuged and 
analyzed by GCMS analysis using an Agilent 6890N GC linked to a 5975B Mass 
detector. 
The identification of compounds producing peaks in the total ion chromatograms 
(TIC) was done using both the Wiley and AMDIS databases, as well as data 
published in the literature. Specifically, the Chemstation software linked to the 
GCMS was used to acquire the TIC and their associated spectra. The resulting 
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peaks and their associated spectra were then searched using the Wiley 375 Mass 
Spectra database. Due to the complexity of the chromatograms, there is a certain 
degree of the spectral overlap and to overcome this, the Automated Mass Spectral 
Deconvolution and Identification Software (AMDIS) was used to separate multiple 
overlapping spectra lying within single chromatographic peaks. The spectra of the 
separated components were then compared with the spectra of National Institute 
of Standard and Technology (NIST) 05 Mass Spectral databases which has about 
215 339 stored spectra. The identity of the spectra above 95% was needed for the 
identification of components  
 
5.3. Results and discussion 
5.3.1. Qualitative phytochemical screening 
The phytochemical screening of the Gnidia polycephala and Senecio serratuloides 
extracts revealed the presence of secondary metabolites such as hydrolysable 
tannins in both the Gnidia polycephala and Senecio serratuloides plant material. 
Flavonoids were also determined in Senecio serratuloides plant material. Alkaloid 
and saponins were not determined in both plants. 
The absence of alkaloids from both Gnidia polycephala and Senecio serratuloides 
may explain the poor antimicrobial activities of the plants demonstrated in Chapter 
four of this study. Alkaloids have been described as powerful poisons and 
numerous alkaloids derived from medicinal plants exhibit biological activities such 
as antimicrobial, anti-inflammatory, antimalarial, cytotoxicity, antispasmodic and 
pharmacological effects (Iqbal et al., 2015). Previous phytochemical screening 
identified the presence of alkaloids in S. serratuloides (Gould et al., 2015). The 
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absence of alkaloids from S. serratuloides stems in the present study; could be the 
result of different geographical locations in which soil minerals and environmental 
factors greatly influence the phytochemical contents of a plant (Khanam et al., 
2015). 
 
5.3.2. Gas Chromatography-Mass Spectrometry (GC-MS) 
The GC-MS analysis of the Gnidia polycephala extracts led to the identification of 
the different compounds listed in Table 5.1. 
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Table 5.1: Phytochemical profiles of Gnidia polycephala extracts by GC-MS 
Retention 
Time: 
Area %: Name of Compound: Formula: Match 
Quality %: 
Aqueous Extract: 
5.759 2.946 Benzoic acid C7H6O2 96 
6.12 5.4755 1,2-Benzenediol C6H6O2 86 
7.241 1.1338 Phenol,2,6-dimethoxy- C8H10O3 97 
10.008 9.2697 4-Methoxy-3-
propoxybenzaldehyde 
C11H14O3 74 
10.065 6.6863 Phenol,2,6-dimethoxy-4-
(2-propenyl)- 
 C11H14O3 50 
10.389 7.4402 4-((1E)-3-Hydroxy-1-
propenyl)-2-
methoxyphenol 
C10H12O3 94 
Acetone extract: 
5.781 1.7051 Benzoic acid C7H6O2 95 
6.904 0.7659 2-Methoxy-4-vinylphenol C9H10O2 55 
7.701 0.2486 Vanillin C8H8O3 93 
10.493 0.8685 Tetradecanoic acid C14H28O2 98 
11.002 0.2051 2-
Pentadecanone,6,10,14-
trimethyl- 
 C18H36O 74 
11.884 7.8957 n-Hexadecanoic acid C16H32O2 99 
12.922 5.2287 Linoleic acid C18H32O2 98 
13.064 1.085 Octadecanoic acid C18H36O2 99 
15.539 10.8604 1,2-Benzedicarboxylic 
acid 
 C8H6O4 91 
Methanol Extract 
4.719 0.9804 Thymine C5H6N2O2 47 
5.232 0.768 4H-Pyran-4-one,2,3-
dihydro-3,5-dihydroxy-6-
methyl 
C6H8O4 76 
6.107 0.3575 Benzofuran, 2,3-dihydro-  C8H8O 81 
7.245 0.6356 Phenol,2,6-dimethoxy C8H10O3 91 
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7.701 0.1637 Vanillin C8H8O3 83 
8.096 0.1235 Phenol,2-methoxy-4-(1-
propenyl)-, (E)- 
C10H12O2 91 
10.071 1.66 Phenol,2,6-dimethoxy-4-
(2-propenyl) 
C11H14O3 90 
10.485 1.4437 Tetradecanoic acid  C14H28O2 93 
11.8  n-Hexadecanoic acid C16H32O2  
12.94 12.9008 9,12,15-Octadecatrienoic 
acid (Z, Z, Z)- 
C18H30O2 96 
13.054 0.8549 Octadecanoic acid C18H36O2 96 
 
The compound 4-((1E)-3-Hydroxy-1-propenyl)-2-methoxyphenol (Fig 5.1), was 
identified from the aqueous extract of Gnidia polycephala. This phenolic compound 
is known to have antimicrobial activities (Ravikumar et al., 2012). Surprisingly, the 
aqueous extract of Gnidia polycephala did not display any antimicrobial activity 
against the tested bacteria may be because this compound was present in 
insignificant quantities. This can be attributed to the fact that water is not known as 
the best solvent of extraction for antimicrobial activity (Dzoyem et al., 2016). 
 
Fig 5.1: MS spectrum of 4-((1E)-3-Hydroxy-1-propenyl)-2-methoxyphenol 
Tetradecanoic acid (Fig 5.2), was present in both the methanol and acetone 
extracts of Gnidia polycephala. This compound has been reported to have 
significant larvicidal and repellent activities against mosquitoes (Sivakumar et al., 
2011). It is possible that the presence of this compound can explain the toxic and 
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irritating effects of G. polycephala that have been reported (Bhandurge et al., 
2013). 
 
Fig 5.2: MS spectrum of tetradecanoic acid 
The acetone extract of G. polycephala contained the compound 2-Methoxy-4-
vinylphenol (Fig 5.3), which has antimicrobial, antioxidant and anti-inflammatory 
properties (Ravikumar et al., 2012). This compound may have contributed to the 
antimicrobial activity against S. aureus (section 4.3). 
 
Fig 5.3: MS spectrum of 2-Methoxy-4-vinylphenol 
The GC-MS analysis of the aqueous and acetone of Senecio serratuloides extracts 
led to the identification of 12 compounds listed in Table 5.2. 
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Table 5.2: Phytochemical profiles of Senecio serratuloides extracts by GC-MS 
 
The compound 2-Methoxy-4-vinylphenol (Fig 5.4), identified from the aqueous 
extract of Senecio serratuloides and is reported to have antimicrobial, antioxidant 
and anti-inflammatory (Ravikumar et al., 2012). 
Retention 
Time: 
Area %: Name of Compound: Formula: Match 
Quality 
%: 
Aqueous extract 
4.476 4.476 Phenol, 2-methoxy- C7H8O2 94 
6.2123 4.5338 1,2-Benzenediol C6H6O2 91 
6.8967 8.3153 2-Methoxy-4-vinylphenol C9H10O2 90 
7.2424 3.7713 Phenol,2,6-dimethoxy C8H10O3 97 
10.3396 1.6534 Ethanone,1-(4-hydroxy-
3,5-dimethoxyphenyl)- 
C10H12O4 90 
11.532 1.1821 Hexadecanoic acid, 
methyl ester 
C17H34O2 95 
11.8142 2.3578 n-Hexadecanoic acid C16H32O2 90 
12.2798 3.9323 9-Acetyl-S-
octahydrophenanthrene 
C16H20O 49 
Acetone extract 
11.5322 0.2122 n-Hexadecanoic acid C16H32O2 90 
12.915 0.8783 Linoleic acid C18H32O2 99 
Methanol extract 
11.8567 4.1462 Hexadecanoic acid C16H32O2 99 
13.0632 1.8932 Octadecanoic acid C18H36O2 91 
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Fig 5.4: MS spectrum of 2-Methoxy-4-vinylphenol 
Previous studies have isolated Daphnetin-8-ᵝ-D-glucoside, Umbelliferone,2-O-α-
D-glucosyloxy-4-methoxybenzenepropanoicacid, Methyl2-O-ᵝ-D-glucosyloxy-4-
methoxybenzenepropanoate, 7-O-beta-D-Apiofuranosyl-(1-6)-beta-D-
glucopyranosyl-umbelliferone (adicardin) and 4-((1E)-3-Hydroxyprop-1-en-1-yl)-
2,6-dimethoxyphenyl-ᵝ-D-glucopyranoside from Gnidia polycephala (Bhandurge 
et al.,2013; Munkombwe et al., 2003) but these were not found in this study. A 
crucial trait of medicinal plants is that they do not consistently produce similar 
chemicals in the same quantities. The concentration of the produced 
phytochemicals depends on the growth conditions, storage, and processing of 
the plant material (Boost et al., 2016). 
 
5.4 . Conclusion 
Gnidia polycephala and Senecio serratuloides are commonly used as traditional 
medicinal plants. This study is the first record of the anticancer and cytotoxic, 
antidiabetic and antimicrobial properties of these medicinal plants. In the search 
for novel alternative medicines from medicinal plants, it is required to explore and 
identify potential compounds with medicinal importance. The results of this study 
revealed the presence of various compounds with known medicinal importance. 
Although these compounds were present in insignificant quantities, we 
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recommend further phytochemical investigations on fractions from these medicinal 
plants. 
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CHAPTER 6 
GENERAL DISCUSSION AND CONCLUSION 
6.1. Introduction 
Medicinal plants are considered the best source of novel drug leads in developing 
alternative medicines (Chintamunnee and Mahomoodally, 2012) because of their 
availability and cultural acceptance (Verschaeve et al., 2004). Gnidia polycephala 
and Senecio serratuloides are commonly used as traditional medicinal plants to 
provide relief and therapy to various diseases (Sections 1.6 and 1.7). To date, little 
research has been carried out to evaluate their bioactivity. It is for this reason that 
the bioactivity of the acetone, methanol and aqueous extracts from G. polycephala 
and S. serratuloides was evaluated. Table 6.1 presents a summary of the results. 
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Table 6.1. Bioactivity of extracts from Gnidia polycephala and Senecio serratuloides 
1: Aqueous extract, 2: Methanol extracts 
 Results 
G. polycephala S. serratuloides 
Anticancer activity dH2O1 and MeOH2: inactive 
Acetone: weak  
dH2O: inactive 
MeOH and acetone: weak  
Cytotoxicity dH2O: weak hazard 
MeOH and acetone: low hazard 
dH2O and MeOH: low hazard 
Acetone: weak hazard 
Antidiabetic activity α-amylase inhibition 
dH2O: -11.79% 
MeOH: 10.81 ± 1.32% 
Acetone: 66.34 ± 
0.84% 
α-glucosidase 
inhibition 
dH2O: 54.84 ± 0.65% 
MeOH: 45.43 ± 0.56% 
Acetone: 81.75± 0.86% 
α-amylase inhibition  
dH2O: -0.60% 
MeOH: 6.59± 0.010% 
Acetone: 9.71 ± 0.019% 
α-glucosidase 
inhibition 
dH2O: 28.44 ± 1.98% 
MeOH: 22.95 ± 1.50% 
Acetone: 78.86 ± 
1.10% 
Antimicrobial 
activity 
MeOH: MIC of 10 mg/ml against S. aureus 
Acetone: MIC of 10 mg/ml against S. aureus 
MeOH: MIC of 5 mg/ml against S. aureus 
Acetone: MIC of 5 mg/ml against S. aureus 
Phytochemical 
classes detected  
Hydrolysable tannins Hydrolysable tannins and flavonoids. 
Phytochemical 
compounds 
identified 
4-((1E)-3-Hydroxy-1-propenyl)-2-
methoxyphenol, tetradecanoic acid, and 2-
Methoxy-4-vinylphenol. 
2-Methoxy-4-vinylphenol. 
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6.2. Discussion 
Our studies are in contradiction with the report by Gould et al., (2015) that the 
South African National Biodiversity Institute (SANBI) has classified S. serratuloides 
as a poisonous plant. There are also reports in literature that the Genus Gnidia 
possesses toxic diterpene esters (Franke et al., 2002). Specifically, Gnidia 
polycephala has been reported to be toxic when consumed by livestock 
(Munkombwe et al., 2003). Selectivity of the anticancer activity of G. polycephala 
and S. serratuloides extracts was determined by comparing the anticancer activity 
(IC50) of each plant extract against the cancer cell lines with that of the normal 
human fetal lung fibroblast cell line, the acetone extract of G. polycephala 
demonstrated higher selectivity for the TK10 and UACC62 cell lines. Likewise, the 
acetone extract of S. serratuloides demonstrated higher selectivity for UACC62 
cells, whereas the methanol extract of S. serratuloides demonstrated higher 
selectivity for all cell lines used in this study (Section 2.3). The high selectivity index 
indicates that the extracts offer the potential of safer therapy (Valdẻs et al., 2010). 
Hydrolysable tannins were found in both the Gnidia polycephala and Senecio 
serratuloides extracts, as well as flavonoids in Senecio serratuloides (Table 6.1). 
Literature attributes the antimicrobial activity of most medicinal plants to the 
presence of alkaloids (Iqbal et al., 2015), which were lacking in this study. There is 
also no direct association between tannin content and antibacterial activity (Ahmed 
et al., 2012). This confers with the weak or lack of anticancer (section 2.3) and 
antimicrobial activities (section 4.3) displayed by the tested plant extracts. The 
absence of the other classes of phytochemical compounds could be as a result of 
the difference in geographical locations where our plant samples and the plant 
samples reported in literature to possess these phytochemical classes were 
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collected. This is because soil minerals and environmental factors greatly influence 
the phytochemical contents of a plant (Khanam et al., 2015). Additionally, medicinal 
plants are known not to consistently produce similar chemicals in the same 
quantities. The concentration of the produced phytochemicals depends on the 
biochemical factors within the plant as well as external factors. These include the 
plant part tested, storage and processing of the plant material and climatic 
conditions as well as the type of soil the plant is growing in (Boost et al., 2016; 
Javadi et al., 2015). For instance, this study investigated Gnidia polycephala stem, 
leaves and flower extracts which were prepared as a mixture. On the contrary, 
glycosides, syringin and adicardin were detected from the stem and root extracts 
of the plant in previous studies (Munkombwe et al., 2003). Similarly, the period 
during which the plant is harvested may also have an effect on the composition of 
secondary metabolites of the same plant species and ultimately lead to variations 
in the activity of the same plant species collected at different periods (Buwa and 
Van Staden, 2007). Therefore, the inconsistency or differences of the results of our 
study in comparison to those in literature may be attributed to the possible 
differences in the season in which the plants were harvested, geographic location, 
soil types as well as climatic conditions. 
Another contributing factor may be the age of the investigated plant samples. In 
their study, Hu et al., (2003) found the three-year-old Aloe vera plant they tested 
to possess significantly higher contents of polysaccharide and flavonoids than 
those they found in two- and four- year old Aloe vera plants. 
Alternatively, the investigated plant extracts may not by themselves induce direct 
pharmacological properties but, may enhance the body’s own healing process. For 
instance, previous studies have found S. serratuloides to heal skin wounds in a pig 
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model two days earlier than untreated wounds. This was attributed to the effect of 
the plant on early phases of wound healing because S. serratuloides lowered the 
wound pH and a lower pH is known to promote cellular migration and proliferation. 
An appropriate pH is required for the overall integrity of intact skin in order to 
maintain homeostasis and the correct balance of cellular debris as well the 
modulation of growth factors, cytokines and cytoplasmic receptor domains (Gould 
et al., 2015). Similarly, some anticancer drugs are known to exhibit their antitumor 
activity in vivo but have no in vitro cytotoxic activity. This is reportedly so because 
of immune modulation by the compound which might lead to anticancer activity in 
vivo (Kamahabwa et al., 2000). 
 
6.3. Conclusions and recommendations 
The current study documents the in vitro bioactivity of Gnidia polycephala and 
Senecio serratuloides and further confirm the importance of medicinal plants in the 
search for the discovery and development of alternative drug leads. The Gnidia 
polycephala extracts proved to have the potential to be developed as anti-diabetic 
drugs. We recommend further in vitro experiments to establish the mechanism of 
action from the extracts with high α-amylase and α-glucosidase inhibitory activities 
as well as to determine if the inhibition is as a result of the compounds acting 
synergistically or individually. 
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